Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024

Share This

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.

Latest Mizuho News

The winner of the OpenAI-Anthropic race may not be the first to the IPO finish line

The winner of the OpenAI-Anthropic race may not be the first to the IPO finish line

June 9, 2026

Mizuho Americas wins five FCS Portfolio Awards

Mizuho Americas wins five FCS Portfolio Awards

May 20, 2026

Mizuho Head of Investment: AI is imacting every sector in the global economy

Mizuho Head of Investment: AI is imacting every sector in the global economy

June 9, 2026

Mizuho news from around the globe

Mizuho Global News